SPOPL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.964200E-01
Normal-vs-Stage2
6.453200E-01
Normal-vs-Stage3
9.923600E-02
Normal-vs-Stage4
7.322400E-01
Stage1-vs-Stage2
9.304200E-01
Stage1-vs-Stage3
1.277590E-01
Stage1-vs-Stage4
3.481000E-01
Stage2-vs-Stage3
1.230350E-01
Stage2-vs-Stage4
2.765200E-01
Stage3-vs-Stage4
8.028200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.725600E-01
Normal-vs-AfricanAmerican
9.032400E-01
Normal-vs-Asian
6.676600E-01
Caucasian-vs-AfricanAmerican
5.680600E-01
Caucasian-vs-Asian
9.431000E-01
AfricanAmerican-vs-Asian
6.790400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.769400E-01
Normal-vs-Female
5.336800E-01
Male-vs-Female
4.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.214000E-01
Normal-vs-Age(41-60Yrs)
9.766400E-01
Normal-vs-Age(61-80Yrs)
4.641000E-01
Normal-vs-Age(81-100Yrs)
2.042600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.941200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.578400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.665200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.231500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.091800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.444800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.028400E-01
Normal-vs-Daily Drinker
3.353000E-01
Normal-vs-Weekly Drinker
4.292000E-01
Normal-vs-Occasional Drinker
9.374400E-01
Normal-vs-Social Drinker
6.463000E-01
Non Drinker-vs-Daily Drinker
4.326600E-01
Non Drinker-vs-Weekly Drinker
7.365200E-01
Non Drinker-vs-Occasional Drinker
1.462840E-01
Non Drinker-vs-Social Drinker
7.476400E-01
Daily Drinker-vs-Weekly Drinker
7.422800E-01
Daily Drinker-vs-Occasional Drinker
5.184100E-02
Daily Drinker-vs-Social Drinker
3.520600E-01
Weekly Drinker-vs-Occasional Drinker
1.432350E-01
Weekly Drinker-vs-Social Drinker
5.800600E-01
Occasional Drinker-vs-Social Drinker
3.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.072500E-02
Normal-vs-Grade 2
6.937700E-03
Normal-vs-Grade 3
5.116400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.537030E-01
Grade 1-vs-Grade 3
1.873580E-01
Grade 1-vs-Grade 4
4.072500E-02
Grade 2-vs-Grade 3
9.908400E-01
Grade 2-vs-Grade 4
6.937700E-03
Grade 3-vs-Grade 4
5.116400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.813200E-01
Normal-vs-NonDiabetic
5.701400E-01
Diabetic-vs-NonDiabetic
4.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.370580E-01
Normal-vs-NoPancreatitis
5.701800E-01
Pancreatitis-vs-NoPancreatitis
1.262200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.665400E-01
Normal-vs-N1
6.659800E-01
N0-vs-N1
4.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.898400E-01
Normal-vs-TP53-NonMutant
5.368600E-01
TP53-Mutant-vs-TP53-NonMutant
4.466000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
